US 9675632
Nucleoside and nucleotide derivatives
granted A61KA61K31/7052A61K31/706
Quick answer
US patent 9675632 (Nucleoside and nucleotide derivatives) held by Enanta Pharmaceuticals, Inc. expires Mon Jun 08 2037 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Enanta Pharmaceuticals, Inc.
- Grant date
- Tue Jun 13 2017 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Jun 08 2037 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 17
- CPC classes
- A61K, A61K31/7052, A61K31/706, A61K31/7064, A61K31/7068